Insight

Rodrigo Sánchez-Bayona: Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer

Photo of Rodrigo Sánchez-Bayona from esmo.org

Aug 19, 2024, 10:45

Rodrigo Sánchez-Bayona: Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer

Rodrigo Sánchez-Bayona, Medical Oncologist at 12 de Octubre University Hospital, shared a post on X about a recent paper by Isabel Blancas et al. published in Future Oncology.

“Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain”

Authors: Isabel Blancas, Jessica Grosjean, Rebecca Pedersini, Rodrigo Sanchez-Bayonai, Lucia Del Mastro, Walid Fakhouri et al.

“Just published.

Our contribution to this RWE study: Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain.”

Source: Rodrigo Sánchez-Bayona/X

Abemaciclib cancer France Future Oncology HR+/HER2- metastatic breast cancer Isabel Blancas Italy Jessica Grosjean Lucia Del Mastro OncoDaily Oncology Rebecca Pedersini Rodrigo Sánchez-Bayona Spain Walid Fakhouri

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage